Please login to the form below

Not currently logged in
Email:
Password:

Shield Therapeutics’ CFO steps down

Richard Jones to leave the group in early 2017

Richard Jones is to step down from his position as chief financial officer at Shield Therapeutics early next year.

Jones joined the secondary care pharmaceutical specialist in 2010 as a non-executive director before taking on his current role a year later.

He brought nearly 30 years of financial management experience to the firm, with 16 years specialising in the healthcare sector.

Previously, Jones has served as a healthcare consultant for Grant Thornton's healthcare advisory practice, as a strategic advisory board member for Bionow and in a number of senior corporate finance roles specialising in healthcare.

Carl Sterritt, chief executive officer of Shield Therapeutics, said: “Richard has helped build the Group from its inception as a small private company through to being listed on AIM.

“I would like to thank him for his significant contribution to Shield and wish him the best in his future endeavours as we continue to grow rapidly into a commercial-stage specialty pharmaceutical business with international operations."


23rd November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics